Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT02836808

Validation of an Integrated Attention Model for Patients With Type 2 Diabetes

Led by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Updated on 2018-03-06

1200

Participants Needed

1

Research Sites

791 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores. There is a need for additional studies. The Center for Comprehensive Care of Patients with Diabetes (CAIPaDi) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services.

CONDITIONS

Official Title

Validation of an Integrated Attention Model for Patients With Type 2 Diabetes

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between 18 and 70 years old
  • Have a diagnosis of type 2 diabetes within the last five years
  • Have family support
  • Be free of disabling diabetes complications
Not Eligible

You will not qualify if you...

  • Have advanced diabetes complications such as ischemic heart disease, severe heart failure (NYHA III-IV), advanced kidney failure (KDOQI stage 3 or higher), amputations, stroke, gastroparesis, or muscle atrophy
  • Have type 1 diabetes, gestational diabetes, or diabetes related to genetic syndromes or hyperlabile diabetes
  • Have life-limiting conditions such as malignant tumors
  • Have advanced cognitive impairment or serious psychiatric disorders
  • Smoke, have alcoholism, or illegal drug dependence
  • Have conditions requiring surgery soon or that prevent moderate physical activity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Instituto Nacional de Ciencias Medicas y Nutricion

Mexico City, Mexico City, Mexico, 14000

Actively Recruiting

Loading map...

Research Team

S

Sergio Hernández, MD

CONTACT

C

Carlos A Aguilar-Salinas, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Validation of an Integrated Attention Model for Patients With Type 2 Diabetes | DecenTrialz